HC Advisors, LLC

SEC CIK: 0001803295
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

AKBA holding history

Akebia Therapeutics, Inc. in every 13F filed by HC Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKBA overview All 13F holders of AKBA Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q3 2022

Holdings of AKBA by HC Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−10,000−100.0%	Sold out	Holders
Q3 2022	10,000	$3.00K	<0.1%	+10,000	New	Holders